Global Monoammonium Glycyrrhizinate Market Strategic Research Report

Scope of the Report

The global Monoammonium Glycyrrhizinate market size is predicted to grow from US$ 89.3 million in 2025 to US$ 145 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032.

Monoammonium Glycyrrhizinate (MAG) is a bioactive compound derived from the root of the licorice plant, Glycyrrhiza glabra. It is a white crystalline powder with a special sweet taste and practically no odor. MAG is known for its range of therapeutic properties, including anti-inflammatory, antiviral, and hepatoprotective effects. It is commonly utilized in pharmaceutical and nutraceutical formulations.

In the pharmaceutical industry, MAG is employed for its hepatoprotective properties, making it useful in the treatment of chronic persistent hepatitis, chronic active hepatitis, liver poisoning, and early liver cirrhosis. It is also used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation.

Beyond pharmaceuticals, MAG finds applications in the cosmetics industry due to its anti-inflammatory and skin-soothing properties. It is incorporated into skincare products aimed at reducing redness, irritation, and inflammation. In the food industry, MAG serves as a flavoring agent and sweetener, leveraging its high sweetness and low caloric content.

Regionally, Asia-Pacific holds a significant share of the MAG market, with countries like China and India being major producers and consumers. The presence of key manufacturers and the traditional use of licorice in these regions contribute to this dominance. North America and Europe also represent substantial markets, driven by the pharmaceutical and cosmetic industries' demand for natural compounds.

Monoammonium Glycyrrhizinate is a versatile compound with significant applications across multiple industries. Its natural origin and therapeutic properties make it a valuable ingredient in pharmaceuticals, cosmetics, and food products. The global market is poised for continued growth, driven by increasing consumer demand for natural and effective ingredients

The core manufacturers of Monoammonium Glycyrrhizinate in the world include Jiangsu Tiansheng Pharmaceutical, Alps Pharmaceutical and Shaanxi Fujie Pharmaceutical. The top three companies have a market share of about 46 percent. China is the largest Monoammonium Glycyrrhizinate market in the world with a market share of about 74%, followed by Japan and North America with a market share of 15% and 4%, respectively. In terms of product type, Pharmaceutical Grade is the largest segment with approximately 49% market share.

This report presents a comprehensive overview of the global Monoammonium Glycyrrhizinate market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Pharmaceutical Grade
• Food Grade
• Others

Segment by Application

• Food & Beverages
• Nutraceuticals
• Pharmaceuticals
• Cosmetics
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Monoammonium Glycyrrhizinate market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Food & Beverages, Nutraceuticals, Pharmaceuticals evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact